Verastem reported $78.17M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
AstraZeneca AZN:LN USD 4.46B 359M
Curis CRIS:US USD 29.85M 4.16M
Cytokinetics CYTK:US USD 106.24M 12.61M
Gilead Sciences GILD:US USD 6.94B 2.2B
Immunogen IMGN:US USD 309.51M 64.36M
Laboratory Of America LH:US USD 409.9M 658.9M
Novartis NOVN:VX USD 8.73B 5.1B
Roche Holding ROG:VX 4.32B 2.54B
Tg Therapeutics TGTX:US USD 109.86M 37.21M
Verastem VSTM:US USD 78.17M 14.22M
YTE INCY:US USD 2.69B 255.24M
Ziopharm Oncology ZIOP:US USD 37.81M 22.2M